140 related articles for article (PubMed ID: 7009189)
1. The abrogation of in vivo resistance to parental bone marrow transplantation and of in vitro natural cell-mediated cytotoxicity to the YAC lymphoma by in vivo growth of a transformed thymus-derived cell culture.
Gardner FH; Gallagher MT; Datta SK; Trentin JJ
Exp Hematol; 1980 Sep; 8(8):1040-7. PubMed ID: 7009189
[TBL] [Abstract][Full Text] [Related]
2. Different sensitivities to hydrocortisone of natural killer cell activity and hybrid resistance to parental marrow grafts.
Hochman PS; Cudkowicz G
J Immunol; 1977 Dec; 119(6):2013-5. PubMed ID: 334980
[TBL] [Abstract][Full Text] [Related]
3. Genetic resistance to bone marrow transplantation as a leukemia-lymphoma defense mechanism: correlation of "in vivo" lymphoma resistance and "in vitro" NK activity.
Gallagher MT; Datta SK; Trentin JJ
Biomedicine; 1980 May; 33(3):73-5. PubMed ID: 7004513
[TBL] [Abstract][Full Text] [Related]
4. Suppression of natural killer cell cytotoxicity by splenocytes from Corynebacterium parvum-injected, bone marrow-tolerant, and infant mice.
Savary CA; Lotzová E
J Immunol; 1978 Jan; 120(1):239-43. PubMed ID: 342602
[TBL] [Abstract][Full Text] [Related]
5. Parallelism between the effect of cortisone acetate on hybrid resistance and natural killing.
Lotzová E; Savary CA
Exp Hematol; 1981 Aug; 9(7):766-74. PubMed ID: 7032960
[TBL] [Abstract][Full Text] [Related]
6. Induction of graft-versus-leukemia (GVL) activity in murine leukemia models after IL-2 pretreatment of syngeneic and allogeneic bone marrow grafts.
Zeis M; Uharek L; Glass B; Gaska T; Gassmann W; Mueller-Ruchholtz W
Bone Marrow Transplant; 1994 Nov; 14(5):711-5. PubMed ID: 7889004
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of hybrid resistance by 5-fluorouracil. Destruction of a Thy-1+ Lyt-1+2- spleen cell implicated in the expression of hybrid resistance.
Kosmatopoulos K; Bravo-Cuellar A; Wachowiak J; Orbach-Arbouys S
Transplantation; 1987 Aug; 44(2):202-8. PubMed ID: 2888223
[TBL] [Abstract][Full Text] [Related]
8. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.
Takei F; Levy JG; Kilburn DG
J Immunol; 1976 Feb; 116(2):288-93. PubMed ID: 814160
[TBL] [Abstract][Full Text] [Related]
9. Depression of natural antitumor resistance of C57BL/6 mice by leukemogenic doses of radiation and restoration of resistance by transfer of bone marrow or spleen cells from normal, but not beige, syngeneic mice.
Gorelik E; Herberman RB
J Natl Cancer Inst; 1982 Jul; 69(1):89-93. PubMed ID: 7047834
[TBL] [Abstract][Full Text] [Related]
10. Altered natural killer cell biology in C57BL/6 mice after leukemogenic split-dose irradiation.
Parkinson DR; Brightman RP; Waksal SD
J Immunol; 1981 Apr; 126(4):1460-4. PubMed ID: 7009740
[TBL] [Abstract][Full Text] [Related]
11. Recognition and regulation of progenitor marrow elements by NK cells in the mouse.
O'Brien T; Kendra J; Stephens H; Knight R; Barrett AJ
Immunology; 1983 Aug; 49(4):717-25. PubMed ID: 6192081
[TBL] [Abstract][Full Text] [Related]
12. A new strategy for treatment of malignant tumor: intra-bone marrow-bone marrow transplantation plus CD4- donor lymphocyte infusion.
Suzuki Y; Adachi Y; Minamino K; Zhang Y; Iwasaki M; Nakano K; Koike Y; Ikehara S
Stem Cells; 2005 Mar; 23(3):365-70. PubMed ID: 15749931
[TBL] [Abstract][Full Text] [Related]
13. Kinetics and location of bone marrow cell graft rejection by irradiated mice.
Sentman CL; Streilein R; Kumar V; Bennett M
Nat Immun Cell Growth Regul; 1988; 7(2):95-105. PubMed ID: 3045529
[TBL] [Abstract][Full Text] [Related]
14. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
[TBL] [Abstract][Full Text] [Related]
15. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of natural killer cell-mediated lysis of tumor cells by normal and regenerating bone marrow.
Miller SC; Galley D; Nguyen DM
Immunobiology; 1988 Apr; 177(1):82-90. PubMed ID: 3384448
[TBL] [Abstract][Full Text] [Related]
17. Host reactivity against clonable tumor cells and the total tumor cell population, studied in a syngeneic murine lymphoma system.
Gjedde SB
Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):101-8. PubMed ID: 6349250
[TBL] [Abstract][Full Text] [Related]
18. Mutual recognition of parental and F1 lymphocytes. II. Analysis of graft-vs-host-induced suppressor cell activity for T cell-mediated lympholysis to trinitrophenyl self and alloantigens.
Polisson RP; Shearer GM
J Immunol; 1980 Oct; 125(4):1865-61. PubMed ID: 6967920
[TBL] [Abstract][Full Text] [Related]
19. Genetic resistance to marrow transplantation as a leukemia defense mechanism.
Gallagher MT; Lotzová E; Trentin JJ
Biomedicine; 1976 Feb; 25(1):1-3. PubMed ID: 786397
[TBL] [Abstract][Full Text] [Related]
20. Local inhibition of natural killer cell activity promotes the progressive growth of intraocular tumors.
Apte RS; Mayhew E; Niederkorn JY
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1277-82. PubMed ID: 9152248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
